-
January 11, 2013
Bayer AG's (BAYRY) Bayer CropScience recently signed an agreement to acquire Prophyta GmbH which develops, produces ...
-
January 09, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently provided an update on its performance in 2012 and its plans for 2013. ...
-
January 07, 2013
The HealthCare unit of Bayer AG (BAYRY) recently received the necessary regulatory approval from the Federal Trade ...
-
January 04, 2013
The HealthCare unit of Bayer (BAYRY) recently announced that a phase III trial (DECISION: n=417) of Nexavar ...
-
December 31, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news when the ...
-
December 28, 2012
Bayer Yakuhin Ltd., the Japanese subsidiary of Bayer AG (BAYRY), submitted a marketing authorization application for ...
-
December 26, 2012
We are reverting to a Neutral recommendation on Bayer (BAYRY) as we believe that all the positive news that led to ...
-
December 26, 2012
SAFC Hitech Ltd. a wholly owned subsidiary of Sigma-Aldrich Corporation (SIAL), announced that it has agreed to ...
-
December 12, 2012
Swiss pharmaceutical giant Novartis (NVS) recently presented data from two phase III trials (COMFORT-I and ...
-
December 11, 2012
Swiss pharmaceutical giant Novartis (NVS) recently presented data from two phase III studies comparing Tasigna ...
-
December 10, 2012
Merck (MRK) recently moved its Alzheimer's disease candidate, MK-8931, into a phase II/III study (EPOCH). The study ...
-
December 10, 2012
Roche Holding (RHHBY) recently announced survival data from its phase III CLEOPATRA study on Perjeta (pertuzumab). ...
-
December 04, 2012
Regeneron Pharmaceuticals Inc. (REGN) and partner the HealthCare unit of Bayer (BAYRY) recently received some ...
-
November 27, 2012
Bayer (BAYRY) recently announced that it will not go ahead with its proposed acquisition of nutritional supplement ...
-
November 26, 2012
Bayer (BAYRY) and partner, Johnson & Johnson's (JNJ) Janssen Research and Development unit recently received some ...
-
November 21, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news with the ...
-
November 19, 2012
Two weeks after Bayer offered to buy Schiff for $34 a share, Reckitt Benckiser is offering $42 a share. A bidding ...
-
November 16, 2012
SAFC, the custom manufacturing and services business unit of Sigma-Aldrich Corporation (SIAL), announced that it has ...
-
November 08, 2012
SAFC, the custom manufacturing and services business unit of Sigma-Aldrich Corporation (SIAL) has entered into an ...
-
November 07, 2012
Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
